TY - JOUR
T1 - Psychometric Evaluation of the Weekly Version of the PTSD Checklist for DSM-5
AU - the STRONG STAR Consortium and the Consortium to Alleviate PTSD
AU - Darnell, Benjamin C.
AU - Vannini, Maya Bina N.
AU - Morgan-López, Antonio
AU - Brown, Stephanie E.
AU - Grunthal, Breanna
AU - Hale, Willie J.
AU - Young-McCaughan, Stacey
AU - Fox, Peter T.
AU - McGeary, Donald D.
AU - Resick, Patricia A.
AU - Sloan, Denise M.
AU - Taylor, Daniel J.
AU - Schobitz, Richard P.
AU - Schrader, Christian C.
AU - Yarvis, Jeffrey S.
AU - Keane, Terence M.
AU - Peterson, Alan L.
AU - Litz, Brett T.
N1 - Publisher Copyright:
© The Author(s) 2025.
PY - 2025
Y1 - 2025
N2 - The posttraumatic stress disorder (PTSD) Checklist for Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5; PCL-5) was designed and validated to track symptoms over the past month (PCL-5-M), yet an untested ad hoc weekly version (PCL-5-W) is commonly used to track changes during treatment. We used archival data of clinical trials for the treatment of PTSD in veterans to assess the construct validity of PCL-5-W. Both PCL-5-M and PCL-5-W were found to have configural measurement invariance across four consecutive administrations. The results also indicated at least partial metric and scalar invariance for each version. The reliability estimates of PCL-5-M and PCL-5-W at each time point were equivalent. However, we found a discrepancy with regard to concurrent validity; correlations with the nine-item Patient Health Questionnaire may be meaningfully different between PCL-5-M and PCL-5-W. Nevertheless, overall, the results suggest that PCL-5-W can be validly used to assess PTSD symptoms over time, but factor scores may need to be tracked alongside total scores to address validity concerns.
AB - The posttraumatic stress disorder (PTSD) Checklist for Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5; PCL-5) was designed and validated to track symptoms over the past month (PCL-5-M), yet an untested ad hoc weekly version (PCL-5-W) is commonly used to track changes during treatment. We used archival data of clinical trials for the treatment of PTSD in veterans to assess the construct validity of PCL-5-W. Both PCL-5-M and PCL-5-W were found to have configural measurement invariance across four consecutive administrations. The results also indicated at least partial metric and scalar invariance for each version. The reliability estimates of PCL-5-M and PCL-5-W at each time point were equivalent. However, we found a discrepancy with regard to concurrent validity; correlations with the nine-item Patient Health Questionnaire may be meaningfully different between PCL-5-M and PCL-5-W. Nevertheless, overall, the results suggest that PCL-5-W can be validly used to assess PTSD symptoms over time, but factor scores may need to be tracked alongside total scores to address validity concerns.
KW - construct validity
KW - measurement invariance
KW - measurement-based care
KW - PTSD Checklist for DSM-5
KW - symptom tracking
UR - https://www.scopus.com/pages/publications/105000833340
UR - https://www.scopus.com/inward/citedby.url?scp=105000833340&partnerID=8YFLogxK
U2 - 10.1177/10731911251321929
DO - 10.1177/10731911251321929
M3 - Article
AN - SCOPUS:105000833340
SN - 1073-1911
JO - Assessment
JF - Assessment
ER -